Form 4: BeiGene CFO Julia Wang Sells Shares to Cover Tax Obligations

Julia Wang, CFO of BeiGene, Ltd., sold 899 American Depositary Shares on June 24, 2024, to satisfy tax withholding obligations related to vesting restricted share units.

Summary

• On June 24, 2024, Julia Wang, the Chief Financial Officer of BeiGene, Ltd., sold 899 American Depositary Shares (ADS).
• The sale was executed at a price of $155.66 per ADS.
• The transaction was conducted to cover mandatory tax withholding requirements associated with the vesting of restricted share units.
• Following the transaction, Ms. Wang directly owns 432,731 Ordinary Shares.
• Each American Depositary Share represents 13 Ordinary Shares.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation. It doesn't convey any particularly positive or negative sentiment about the company's prospects.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance or guidance.

Industry Context

Sales of shares by company executives to cover tax obligations upon vesting of restricted stock units are a common practice. This transaction is a routine part of executive compensation and does not necessarily indicate a change in the executive's confidence in the company.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units that vest over time.
• The sale of shares to cover tax obligations is a standard practice across many publicly traded companies.
• Comparable companies such as Amgen, Gilead Sciences, and Regeneron Pharmaceuticals also see similar transactions by their executives.

Stakeholder Impact

• The sale of shares by the CFO has a minimal impact on shareholders as it is a routine transaction.
• The transaction does not directly affect employees, customers, suppliers, or creditors.

Key Dates